MktsMarkets

Acumen Pharmaceuticals, Inc.
NASDAQ: ABOSKey statistics
ABOS News
Stories mentioning ABOS from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 16,484 | 20,526 | 21,968 | 37,125 | 25,266 | 34,569 | 27,247 | 19,533 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 21,149 | 25,199 | 26,513 | 41,750 | 30,370 | 39,597 | 32,265 | 24,381 |
| Operating Income (Loss) | (21,149) | (25,199) | (26,513) | (41,750) | (30,370) | (39,597) | (32,265) | (24,381) |
| Interest Income | 1,064 | 1,322 | 1,639 | 2,015 | 2,471 | 2,992 | 3,504 | 3,816 |
| Interest Expense | ||||||||
| Other Expense | (43.00) | (4.00) | (69.00) | (129.00) | (64.00) | (62.00) | 33.00 | (68.00) |
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (20,737) | (25,138) | (26,451) | (40,950) | (28,796) | (37,154) | (29,765) | (20,537) |
| Earnings Per Share (Basic) | (0.33) | (0.42) | (0.44) | (0.68) | (0.48) | (0.62) | (0.50) | (0.34) |
| Earnings Per Share (Diluted) | (0.33) | (0.42) | (0.44) | (0.68) | (0.48) | (0.62) | (0.50) | (0.34) |
| Weighted Average Shares Outstanding (Basic) | 63,219 | 60,562 | 60,573 | 60,573 | 60,526 | 60,013 | 60,080 | 60,080 |
| Weighted Average Shares Outstanding (Diluted) | 63,219 | 60,562 | 60,573 | 60,573 | 60,526 | 60,013 | 60,080 | 60,080 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About ABOS
Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) is a stock listed on the Nasdaq Stock Market under the ticker symbol ABOS. It last traded at $2.29 (Oct 29, 2026, 9:30 AM ET), down 3.8% on the day. That gives Acumen Pharmaceuticals a market capitalisation of $163.4M.
Over the past 52 weeks ABOS has traded between $1.50 and $3.60.
For the quarter ended Mar 31, 2026 it reported a net loss of $20.7M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$20.7M |
| Dec 31, 2025 | — | -$25.1M |
| Sep 30, 2025 | — | -$26.5M |
| Jun 30, 2025 | — | -$41.0M |
From Acumen Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…